Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer

The clinical outcome of resectable non–small‐cell lung cancer (NSCLC) patients receiving neoadjuvant chemoimmunotherapy is good but varies greatly. In addition, the pathological response after neoadjuvant chemoimmunotherapy is significantly associated with survival outcomes. The aim of this retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Rui, Zhang, Yimin, Wang, Tianhu, Xiao, Hualiang, Luo, Zhilin, Shen, Cheng, Li, Jianghua, Zhao, Chenglong, Li, Li, Zhu, Mengxiao, Du, Haiwei, Tang, Huan, Ma, Zheng, Wang, Yubo, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236616/
https://www.ncbi.nlm.nih.gov/pubmed/36880750
http://dx.doi.org/10.1111/cas.15778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236616/
https://www.ncbi.nlm.nih.gov/pubmed/36880750
http://dx.doi.org/10.1111/cas.15778

Ejemplares similares